CRC: Emerging Immunotherapy Strategies in MSS Tumors – OncLive
OncLive |
CRC: Emerging Immunotherapy Strategies in MSS Tumors
OncLive Panelists: John L. Marshall, MD, Georgetown University Hospital; Dirk Arnold, MD, PhD, Instituto CUF de Oncologia; University of Hamburg; Fortunato Ciardiello, MD, PhD, Seconda Università di Napoli; Paul R. Helft, MD, Indiana School of Medicine of the … |
